KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMY) Intangibles (2016 - 2025)

Bristol Myers Squibb (BMY) has disclosed Intangibles for 16 consecutive years, with $21.4 billion as the latest value for Q2 2025.

  • On a quarterly basis, Intangibles fell 27.35% to $21.4 billion in Q2 2025 year-over-year; TTM through Jun 2025 was $21.4 billion, a 27.35% decrease, with the full-year FY2024 number at $23.3 billion, down 13.91% from a year prior.
  • Intangibles was $21.4 billion for Q2 2025 at Bristol Myers Squibb, down from $22.5 billion in the prior quarter.
  • In the past five years, Intangibles ranged from a high of $50.8 billion in Q1 2021 to a low of $21.4 billion in Q2 2025.
  • A 5-year average of $32.6 billion and a median of $29.4 billion in 2024 define the central range for Intangibles.
  • Peak YoY movement for Intangibles: dropped 13.91% in 2024, then decreased 27.35% in 2025.
  • Bristol Myers Squibb's Intangibles stood at $42.5 billion in 2021, then dropped by 15.68% to $35.9 billion in 2022, then decreased by 24.5% to $27.1 billion in 2023, then decreased by 13.91% to $23.3 billion in 2024, then dropped by 8.28% to $21.4 billion in 2025.
  • Per Business Quant, the three most recent readings for BMY's Intangibles are $21.4 billion (Q2 2025), $22.5 billion (Q1 2025), and $23.3 billion (Q4 2024).